Cover Image
市場調查報告書

慢性硬腦膜下血腫:全球臨床實驗檢討

Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 306654
出版日期 內容資訊 英文 60 Pages
訂單完成後即時交付
價格
Back to Top
慢性硬腦膜下血腫:全球臨床實驗檢討 Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年06月20日 內容資訊: 英文 60 Pages
簡介

本報告提供慢性硬腦膜下血腫相關的臨床研究最新趨勢分析,為您彙整疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,地區、Phase、階段別的進展,有潛力的贊助商,各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 慢性硬腦膜下血腫
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,慢性硬腦膜下血腫臨床實驗數量比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7(新興7個國家)各國臨床實驗數量:中樞神經系統疾病臨床實驗數量中,慢性硬腦膜下血腫臨床實驗數量比例

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Octapharma AG
    • Kantonsspital Aarau AG
  • 有代表性的研究機關·醫院臨床實驗概要
    • Tianjin Medical University General Hospital
    • Ministry of Education, Culture, Sports, Science and Technology
    • Montpellier University Hospital
    • Addenbrooke's Hospital
    • Department of Neurosurgery, University Hospital
    • 琦玉醫科大學
    • Charite - Universitatsmedizin Berlin
    • Eastern Virginia Medical School
    • University of Virginia
    • Islamic Azad University of Tabriz

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2202CTIDB

GlobalData's clinical trial report, "Chronic Subdural Hematoma Global Clinical Trials Review, H1, 2014" provides data on the Chronic Subdural Hematoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Subdural Hematoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Subdural Hematoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Chronic Subdural Hematoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Chronic Subdural Hematoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Chronic Subdural Hematoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Octapharma AG
      • Clinical Trial Overview of Octapharma AG
      • Kantonsspital Aarau AG
      • Clinical Trial Overview of Kantonsspital Aarau AG
    • Clinical Trial Overview of Top Institutes / Government
      • Tianjin Medical University General Hospital
      • Clinical Trial Overview of Tianjin Medical University General Hospital
      • Ministry of Education, Culture, Sports, Science and Technology
      • Clinical Trial Overview of Ministry of Education, Culture, Sports, Science and Technology
      • Montpellier University Hospital
      • Clinical Trial Overview of Montpellier University Hospital
      • Addenbrooke's Hospital
      • Clinical Trial Overview of Addenbrooke's Hospital
      • Department of Neurosurgery, University Hospital
      • Clinical Trial Overview of Department of Neurosurgery, University Hospital
      • Saitama Medical University
      • Clinical Trial Overview of Saitama Medical University
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • Eastern Virginia Medical School
      • Clinical Trial Overview of Eastern Virginia Medical School
      • University of Virginia
      • Clinical Trial Overview of University of Virginia
      • Islamic Azad University of Tabriz
      • Clinical Trial Overview of Islamic Azad University of Tabriz
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Chronic Subdural Hematoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Subdural Hematoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chronic Subdural Hematoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kantonsspital Aarau AG, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tianjin Medical University General Hospital, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Education, Culture, Sports, Science and Technology, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Montpellier University Hospital, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Addenbrooke's Hospital, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Neurosurgery, University Hospital, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Virginia Medical School, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2014*

List of Figures

  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Chronic Subdural Hematoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Subdural Hematoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Chronic Subdural Hematoma to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Chronic Subdural Hematoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chronic Subdural Hematoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chronic Subdural Hematoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top